Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07413159 · ClinicalTrials.gov registry record · NA

The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.

A NA study of Hypertension, sponsored by Texas Southern University.

Recruiting
Registry status
NA
Development phase
480
Enrollment target
1
Study location

NCT07413159: Recruiting NA study of Hypertension, sponsored by Texas Southern University.

NCT07413159 is a NA study of Hypertension that is actively recruiting participants, run by Texas Southern University. The registered enrollment target is 480 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07413159, a NA study of Hypertension, is actively recruiting participants, sponsored by Texas Southern University.

RECRUITING
Registry status
NA
Development phase
480 participants
Enrollment target
1
Study location

Study Summary

The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Americans, contributing to higher rates of cardiovascular disease and stroke. This project aims to improve clinical and behavioral outcomes through a 24-month intervention combining pharmacist-led counseling and Community Health Worker (CHW) support.

Conditions Studied

Interventions

  • OTHER Pharmacists Only (Control Group)
  • OTHER Combined Intervention (Pharmacists + CHW Interventions)

Study Locations (1)

Texas

  • 3100 Cleburne Street, Nabrit Science Building, - Houston

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2026-04-01
Est. Completion 2030-05-31
Phase NA

Sponsor

Texas Southern University

1 total trials

What the Registry Record Tells You About NCT07413159

The ClinicalTrials.gov registry entry for NCT07413159 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The listed sponsor is Texas Southern University, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Pharmacists Only (Control Group) is the first listed.

NCT07413159 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07413159 about?

NCT07413159 is a clinical study titled "The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.". The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Am...

What is the current status of trial NCT07413159?

This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2026-04-01. Estimated completion is 2030-05-31.

What conditions does trial NCT07413159 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT07413159?

The interventions under investigation include: Pharmacists Only (Control Group) (OTHER), Combined Intervention (Pharmacists + CHW Interventions) (OTHER).

Who is sponsoring clinical trial NCT07413159?

This trial is sponsored by Texas Southern University, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07413159 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.